Answers are grounded in this paper and cite their sources.
This Viewpoint discusses the basis for the FDA’s 2016 approval of the blood-based septin 9 gene (SEPT9) assay as a screening test for colon cancer and concerns about its accuracy and use in clinical practice.
No takes yet. Share an insight, caveat, or question.
Parikh et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: